Trials / Terminated
TerminatedNCT02372695
Effect of Paricalcitol Over Vessel Wall
Effect of Paricalcitol Over Vessel Wall: Pleiotropic Analogues Vitamin D Effects
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Effice Servicios Para la Investigacion S.L. · Industry
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To provide evidence based prospectives of the potential benefit effects of paricalcitol, an analog of vitamin D, over the prevention / retardation of the progression of neoangiogenesis (vessels), atherosclerosis and vascular calcification.
Detailed description
Providing prospective results based on evidence of potential beneficial effects of paricalcitol, an analogue of vitamin D in the prevention / delay of progression of neoangiogenesis (vessels), atherosclerosis and vascular calcification.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paricalcitol |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2015-02-26
- Last updated
- 2015-02-26
Source: ClinicalTrials.gov record NCT02372695. Inclusion in this directory is not an endorsement.